HUP9901464A2 - Eljárás baktériumtörzsek kiválasztására - Google Patents
Eljárás baktériumtörzsek kiválasztásáraInfo
- Publication number
- HUP9901464A2 HUP9901464A2 HU9901464A HUP9901464A HUP9901464A2 HU P9901464 A2 HUP9901464 A2 HU P9901464A2 HU 9901464 A HU9901464 A HU 9901464A HU P9901464 A HUP9901464 A HU P9901464A HU P9901464 A2 HUP9901464 A2 HU P9901464A2
- Authority
- HU
- Hungary
- Prior art keywords
- bacterial strains
- receptors
- antibody
- subject
- strains
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 241000894006 Bacteria Species 0.000 title 1
- 230000001580 bacterial effect Effects 0.000 abstract 6
- 230000001717 pathogenic effect Effects 0.000 abstract 3
- 208000031737 Tissue Adhesions Diseases 0.000 abstract 2
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
A találmány tárgyát képezi eljárás patogén baktériumtörzsek szövetiadhéziójának receptorhelyeire kötődni képes, nem patogénbaktériumtörzsek kiválasztására, amely során a) a receptorokat invitro érintkeztetik a tesztelendő baktériumtörzsekkel; b) a receptorokellen készült, adott esetben kimutatható módon megjelölt antitestetadnak az elegyhez; c) amennyiben az antitest maga nincs megjelölvekimutatható módon, az antitest kimutatására alkalmas vegyületet adnakhozzá; d) kimutatják az antitest és az izolált receptorok közöttkialakult komplex jelenlétét. A találmány tárgyát képezik továbbá atalálmány szerinti eljárással kiválasztott baktériumtörzsekettartalmazó terápiás készítmények és a baktériumtörzsek alkalmazásai. Atalálmány szerinti megoldás alkalmas szöveti adhéziót közvetítőreceptorokhoz kötődő patogén bakteriális törzsek, előnyösenenterotoxinogén E. coli törzsek, okozta fertőzésekkel kapcsolatospatológiás rendellenességek megelőzésére vagy kezelésére. Ó
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9805559A FR2778187B1 (fr) | 1998-04-30 | 1998-04-30 | Procede de selection de souches bacteriennes |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP9901464A2 true HUP9901464A2 (hu) | 2004-12-28 |
Family
ID=9525954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9901464A HUP9901464A2 (hu) | 1998-04-30 | 1999-04-29 | Eljárás baktériumtörzsek kiválasztására |
Country Status (9)
Country | Link |
---|---|
US (1) | US6346422B1 (hu) |
EP (1) | EP0955545A1 (hu) |
JP (1) | JP2000023694A (hu) |
AU (1) | AU759293B2 (hu) |
CA (1) | CA2270754A1 (hu) |
FR (1) | FR2778187B1 (hu) |
HU (1) | HUP9901464A2 (hu) |
NO (1) | NO992092L (hu) |
NZ (1) | NZ335519A (hu) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040241784A1 (en) * | 2001-06-14 | 2004-12-02 | Pascal Butty | Method of selecting non-pathogenic gram-positive lactic acid bacteria strains |
FR2831555A1 (fr) * | 2001-10-29 | 2003-05-02 | Ceva Sante Animale | Procede de selection de souches de bacteries lactiques a gram positif non pathogenes capables de lutter contre des infections par des bacteries pathogenes |
FR2826020B1 (fr) * | 2001-06-14 | 2005-02-11 | Ceva Sante Animale | Procede de selection de souches de bacteries lactiques a gram positif non pathogenes capables de lutter contre des infections par des bacteries pathogenes |
WO2004009031A2 (en) * | 2002-07-22 | 2004-01-29 | Agtech Products, Inc. | Lactobacillus strains and uses therefor |
DE10309349B4 (de) * | 2003-03-03 | 2005-11-10 | Micronas Holding Gmbh | Vorrichtung zur Untersuchung eines Analyten |
US7384628B2 (en) * | 2003-06-23 | 2008-06-10 | Agtech Products, Inc. | Lactic acid bacteria and its use in direct-fed microbials |
US7618640B2 (en) * | 2004-05-14 | 2009-11-17 | Agtech Products, Inc. | Method and composition for reducing E. coli disease and enhancing performance |
US7754469B2 (en) * | 2005-11-30 | 2010-07-13 | Agtech Products, Inc | Microorganisms and methods for treating poultry |
US8021654B2 (en) | 2008-03-14 | 2011-09-20 | Danisco A/S | Methods of treating pigs with Bacillus strains |
DK2274415T3 (da) * | 2008-04-17 | 2016-04-04 | Dupont Nutrition Biosci Aps | Anvendelige bacillestammer til bekæmpelse af dyrelugt |
US8540981B1 (en) | 2008-07-07 | 2013-09-24 | Dupont Nutrition Biosciences Aps | Bacillus strains useful against calf pathogens and scours |
US8557234B1 (en) | 2011-05-18 | 2013-10-15 | Dupont Nutrition Biosciences Aps | Methods of controlling pit foam |
US9089151B2 (en) | 2011-08-24 | 2015-07-28 | Dupont Nutrition Biosciences Aps | Enzyme producing Bacillus strains |
CN103091272B (zh) * | 2013-01-16 | 2015-01-14 | 中国科学院东北地理与农业生态研究所 | 一种利用大肠杆菌生长od值检测污水中锰含量的方法 |
WO2018015380A1 (en) * | 2016-07-18 | 2018-01-25 | Philippe Ulsemer | Natural microorganisms which are naturally capable of binding toxins and/or toxin receptors |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5164298A (en) * | 1988-06-24 | 1992-11-17 | Hsc Research Development Corporation | Verocytotoxin receptor assay |
US4910024A (en) * | 1988-07-05 | 1990-03-20 | Micro Chemical, Inc. | Method and apparatus for administering live bacteria as feed additives to livestock and poultry |
US5206015A (en) * | 1989-06-05 | 1993-04-27 | The United States Of America As Represented By The Secretary Of Agriculture | Introduction of bacteria in ovo |
US5308615A (en) * | 1992-01-17 | 1994-05-03 | The United States Of America As Represented By The Secretary Of Agriculture | Probiotic for control of Salmonella |
US5340577A (en) * | 1992-07-29 | 1994-08-23 | The United States Of America, As Represented By The Secretary Of Agriculture | Probiotic for control of salmonella |
US5413785A (en) * | 1993-01-27 | 1995-05-09 | New England Deaconess Hospital Corp. | Methodology employing lactobacillus GG for reduction of plasma endotoxin levels circulating in-vivo |
US5798260A (en) * | 1994-06-24 | 1998-08-25 | Children's Hospital And Medical Center | Escherichia coli O157:H7 epithelial adhesin |
US5625124A (en) * | 1994-07-11 | 1997-04-29 | Washington University | Animal model for helicobacter pylori infection |
WO1996004364A1 (en) * | 1994-07-29 | 1996-02-15 | The United States Of America, Represented By The Secretary, Department Of Agriculture | Saccharomyces treatment to diminish campylobacter and salmonella populations in poultry |
AU702405B2 (en) * | 1994-09-06 | 1999-02-18 | Immucell Corporation | Therapeutic treatment of clostridium difficile associated diseases |
JP2000505642A (ja) * | 1995-10-20 | 2000-05-16 | ネーデルランドセ・オルガニザテイエ・フール・テゲパスト−ナトウールベテンシヤツペリーク・オンデルツエク・テイエヌオー | 非病原性微生物の新規接着因子および特定の共生的性質について微生物をスクリーニングするためのその適用;そのような微生物と接着因子とを含む新規薬剤学的組成物および食品添加物 |
AUPN698495A0 (en) * | 1995-12-06 | 1996-01-04 | Pharma Pacific Pty Ltd | Improved therapeutic formulation and method |
DE29724815U1 (de) * | 1997-01-09 | 2004-07-22 | Société des Produits Nestlé S.A. | Probiotik enthaltendes Getreideprodukt |
US6100388A (en) * | 1998-03-16 | 2000-08-08 | Biogaia Biologies Ab | Lactobacilli harboring aggregation gene as a vaccine delivery vehicle |
-
1998
- 1998-04-30 FR FR9805559A patent/FR2778187B1/fr not_active Expired - Lifetime
-
1999
- 1999-04-27 EP EP99401025A patent/EP0955545A1/fr not_active Withdrawn
- 1999-04-27 AU AU23988/99A patent/AU759293B2/en not_active Ceased
- 1999-04-29 US US09/301,559 patent/US6346422B1/en not_active Expired - Fee Related
- 1999-04-29 HU HU9901464A patent/HUP9901464A2/hu unknown
- 1999-04-29 CA CA002270754A patent/CA2270754A1/fr not_active Abandoned
- 1999-04-29 NO NO992092A patent/NO992092L/no not_active Application Discontinuation
- 1999-04-30 JP JP11124251A patent/JP2000023694A/ja active Pending
- 1999-04-30 NZ NZ335519A patent/NZ335519A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU2398899A (en) | 1999-11-11 |
FR2778187A1 (fr) | 1999-11-05 |
FR2778187B1 (fr) | 2001-06-22 |
NO992092L (no) | 1999-11-01 |
US6346422B1 (en) | 2002-02-12 |
AU759293B2 (en) | 2003-04-10 |
CA2270754A1 (fr) | 1999-10-30 |
NZ335519A (en) | 2000-08-25 |
JP2000023694A (ja) | 2000-01-25 |
NO992092D0 (no) | 1999-04-29 |
EP0955545A1 (fr) | 1999-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9901464A2 (hu) | Eljárás baktériumtörzsek kiválasztására | |
MXPA02011656A (es) | Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos. | |
AU3262497A (en) | Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression | |
WO2005014035A3 (en) | Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest | |
EP1470146B8 (en) | Antibodies against the muc18 antigen | |
WO1999051748A3 (en) | Fusion proteins of mycobacterium tuberculosis antigens and their uses | |
CA2381770A1 (en) | Human ctla-4 antibodies and their uses | |
HK1046287A1 (en) | Ibd-associated microbial antigens and methods of using same | |
WO2005062972A3 (en) | Treatment of cancer with novel anti-il 13 monoclonal antibodies | |
DE69703121D1 (de) | Verfahren und zusammensetzungen zur verhinderung von entzündungen und angiogenese enthaltend säugetieren cd97 alpha untereinheit | |
ATE465257T1 (de) | Agonisten für den rezeptor des hepatozyten- wachstumsfaktors und deren anwendungen | |
ATE165395T1 (de) | Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen | |
MXPA02012743A (es) | Moleculas tipo il-17 y usos de las mismas. | |
WO2003066661A3 (en) | Human dr4 antibodies and uses thereof | |
FR2610631B1 (fr) | Molecules comportant au moins une sequence peptidique porteuse d'un ou plusieurs, epitope caracteristique d'une proteine produite par p. falciparum dans les hepatocytes, et leurs utilisations, notamment pour le diagnostic du paludisme ou dans des compositions de vaccins contre le paludisme | |
WO2001044177A3 (en) | Somatostatin analogs, radiolabelled derivatives thereof and their use | |
WO2002081745A3 (en) | Genes involved in osteogenesis, and methods of use | |
CA2361987A1 (en) | Goodpasture antigen binding protein | |
WO2000055194A3 (en) | Tuberculosis antigens and methods of use therefor | |
IL159479A (en) | Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis | |
EP1183330A4 (en) | KV10, A NEW POTASSICAL CHANNEL CONTROLED BY VOLTAGE FROM A HUMAN BRAIN | |
EP0916670A3 (en) | Pyrrolo-(3,2-b) pyridines and their use as 5-HT1F agonists | |
WO2001041813A3 (en) | Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof | |
AU2001292118A1 (en) | Dye-labelled peptide and its diagnostic use | |
WO2002086067A3 (en) | Mycobacterial sulfation pathway proteins and methods of use thereof |